HK1251583A1 - 在親和層析中減少宿主細胞蛋白的方法 - Google Patents

在親和層析中減少宿主細胞蛋白的方法

Info

Publication number
HK1251583A1
HK1251583A1 HK18110895.5A HK18110895A HK1251583A1 HK 1251583 A1 HK1251583 A1 HK 1251583A1 HK 18110895 A HK18110895 A HK 18110895A HK 1251583 A1 HK1251583 A1 HK 1251583A1
Authority
HK
Hong Kong
Prior art keywords
reduction
host cell
affinity chromatography
cell proteins
proteins
Prior art date
Application number
HK18110895.5A
Other languages
English (en)
Inventor
Roberto Falkenstein
Wolfgang Koehnlein
Klaus Schwendner
Bernhard Spensberger
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54064133&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1251583(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1251583A1 publication Critical patent/HK1251583A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C07K16/2854Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31Immunoglobulins specific features characterized by aspects of specificity or valency multispecific

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK18110895.5A 2015-08-21 2018-08-23 在親和層析中減少宿主細胞蛋白的方法 HK1251583A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15181903 2015-08-21
PCT/EP2016/069163 WO2017032611A1 (en) 2015-08-21 2016-08-11 Method for the reduction of host cell proteins in affinity chromatography

Publications (1)

Publication Number Publication Date
HK1251583A1 true HK1251583A1 (zh) 2019-02-01

Family

ID=54064133

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18110895.5A HK1251583A1 (zh) 2015-08-21 2018-08-23 在親和層析中減少宿主細胞蛋白的方法

Country Status (10)

Country Link
US (2) US20180186865A1 (zh)
EP (1) EP3337817B1 (zh)
JP (1) JP7073253B2 (zh)
CN (1) CN107835819A (zh)
ES (1) ES2897965T3 (zh)
HK (1) HK1251583A1 (zh)
HR (1) HRP20211737T1 (zh)
PL (1) PL3337817T3 (zh)
SI (1) SI3337817T1 (zh)
WO (1) WO2017032611A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018001511A2 (pt) 2015-08-21 2018-09-18 Hoffmann La Roche ?uso de solução aquosa com baixa condutividade e métodos de produção e purificação de anticorpo de isótipo igg1 ou igg4 humano
CN112876567A (zh) * 2019-11-29 2021-06-01 广东菲鹏制药股份有限公司 Fc融合蛋白及其纯化方法
TWI787710B (zh) * 2020-01-20 2022-12-21 中國大陸商上海藥明生物技術有限公司 用於親和層析的新型清洗緩衝液

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9203459D0 (en) * 1992-02-19 1992-04-08 Scotgen Ltd Antibodies with germ-line variable regions
TWI338009B (en) * 2001-10-29 2011-03-01 Genentech Inc Antibodies for inhibiting blood coagulation and methods of use thereof
SI2261230T1 (sl) * 2002-09-11 2017-08-31 Chugai Seiyaku Kabushiki Kaisha Postopek čiščenja proteinov
TWI306862B (en) 2005-01-03 2009-03-01 Hoffmann La Roche Antibodies against il-13 receptor alpha 1 and uses thereof
EP2824183B1 (en) * 2005-04-08 2020-07-29 Chugai Seiyaku Kabushiki Kaisha Methods for producing bispecific antibodies
AU2006259298B2 (en) * 2005-06-17 2012-06-14 Wyeth Llc Methods of purifying Fc region containing proteins
WO2010056550A1 (en) * 2008-10-29 2010-05-20 Wyeth Llc Methods for purification of single domain antigen binding molecules
WO2011038894A1 (en) * 2009-10-01 2011-04-07 F. Hoffmann-La Roche Ag Protein a chromatography
EP2583973B1 (en) 2010-06-21 2018-03-21 Kyowa Hakko Kirin Co., Ltd. Method for purifying protein using amino acid
WO2012164046A1 (en) * 2011-06-01 2012-12-06 Novartis Ag Wash solution and method for affinity chromatography
AR096713A1 (es) 2013-06-25 2016-01-27 Cadila Healthcare Ltd Proceso de purificación para anticuerpos monoclonales
SG11201601823TA (en) 2013-09-13 2016-04-28 Genentech Inc Methods and compositions comprising purified recombinant polypeptides
JP2015083558A (ja) * 2013-09-18 2015-04-30 東ソー株式会社 抗体吸着剤ならびにそれを用いた抗体の精製方法および識別方法
BR112018001511A2 (pt) 2015-08-21 2018-09-18 Hoffmann La Roche ?uso de solução aquosa com baixa condutividade e métodos de produção e purificação de anticorpo de isótipo igg1 ou igg4 humano

Also Published As

Publication number Publication date
SI3337817T1 (sl) 2021-12-31
PL3337817T3 (pl) 2022-01-17
US20220119499A1 (en) 2022-04-21
CN107835819A (zh) 2018-03-23
EP3337817A1 (en) 2018-06-27
ES2897965T3 (es) 2022-03-03
JP7073253B2 (ja) 2022-05-23
EP3337817B1 (en) 2021-09-15
US20180186865A1 (en) 2018-07-05
WO2017032611A1 (en) 2017-03-02
HRP20211737T1 (hr) 2022-02-18
JP2018525408A (ja) 2018-09-06

Similar Documents

Publication Publication Date Title
HK1251584A1 (zh) 在親和層析中減少宿主細胞蛋白的方法
HK1244019A1 (zh) 融合蛋白
EP3140763A4 (en) Binding affinity prediction system and method
EP3297661A4 (en) Method of improving characteristics of proteins
EP3010527A4 (en) Method for assessing protein identity and stability
IL250165A0 (en) Cation exchange chromatographic support and method for using it
EP3290432A4 (en) HIGH PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR MIXTURES OF POLYPEPTIDES
IL257170A (en) Stable proteins and methods for their design
IL290358A (en) Preparations and methods for detecting host cell proteins
HK1248272A1 (zh) 宿主細胞蛋白質修飾
SG11201701965VA (en) Soluble intein fusion proteins and methods for purifying biomolecules
EP3298151A4 (en) METHOD AND COMPOSITIONS FOR DETERMINING THE PH VALUE
HUP1500363A2 (en) Method for increasing the galactose content of recombinant proteins
EP3265470A4 (en) Electrophoresis and electroblotting systems and methods
EP3312278A4 (en) Protein expression method
IL259181A (en) Opposite ph-salt gradients for improved protein separations
EP3398102A4 (en) METHODS FOR PROTEOME LOCKING IN ORDER TO IDENTIFY PROTEIN-LIGAND INTERACTIONS
HK1251583A1 (zh) 在親和層析中減少宿主細胞蛋白的方法
EP3260862A4 (en) Method for suppressing protein adsorption
EP3299450A4 (en) Induced syncytiotrophoblast and preparation method for progenitor cell thereof
GB201503218D0 (en) Particles comprising fusion proteins
EP3347477A4 (en) COMPOSITIONS AND METHODS FOR PROTEIN DETECTION
EP3333571A4 (en) PARALLEL QUANTIFICATION METHOD OF PROTEIN VARIANT
SG10202010606YA (en) Method for reducing the trisulfide level in proteins
EP3380844A4 (en) PROCESS FOR CHECKING THE PRIMARY STRUCTURE OF PROTEIN